This special issue "Nanomedicine and Cancer Immunotherapy" was organized for the celebration of the 40th anniversary (1980-2020) of Acta Pharmacologica Sinica (APS).The prime aim for the special issue is to deliver both high-impact review and research articles to the wide international readership regarding the most recent progress in nano-immunotherapy as well as the approaches for enhancing the efficacy of cancer immunotherapy.